Now working at Johns Hopkins Community Physicians, Steigerwald discusses leaving their hometown and finding a calling in medicine.

Johns Hopkins neurosurgeons are among the first in the U.S. to use magnetic resonance guided focused ultrasound, also known as MRgFUS, to investigate how it may be applied to ablate diseased tissue and traverse the blood-brain barrier.

A course based in local art museums helps third-year and fourth-year medical students build their professional identities.

Researchers show that screening urine for ctDNA as part of a two-stage test increases detection sensitivity from 40% to 77% in early-stage liver cancer, and from 62% to 92% in the very early stage of disease.

Patients have options for novel therapies and diagnostics at hospitals close to where they live.

New research by Johns Hopkins vascular surgeon predicts which patients will have positive surgical outcomes.

Kalyani’s latest book highlights top athletes who’ve flourished because of their condition.

Migeon led field-defining research in X-inactivation.

Pakula left a far-reaching legacy at Johns Hopkins and beyond.

Partin led research and discovery in the field of urology.

Matthews heads the new International African American Museum in Charleston.

As chief medical officer for USA Nordic, Chen is advocating for national safety standards.

This issue's note from the editor, plus letters from our readers.

The slope that ends in health inequities begins with our own unconscious bias.

Summer learning can be the first step in creating a more diverse health care workforce.

Stigmatizing language in medical records follows patients, potentially exacerbating racial inequities, says Mary Catherine Beach, who is on a mission to raise awareness among physicians.

New ways to treat depression could begin in the gut, according to recent experiments in mice and humans led by Johns Hopkins Medicine researchers. 

A quick clinical test developed by researchers at Johns Hopkins Medicine and several other institutions could predict which people with neck pain are more likely to benefit from epidural steroid injections, which deliver drugs directly around the spinal nerves to stop nerve inflammation and reduce pain.

A new drug, a monoclonal antibody known as enoblituzumab, is safe in men with aggressive prostate cancer and may induce clinical activity against cancer throughout the body, according to a phase 2 study led by investigators at the Johns Hopkins Kimmel Cancer Center and its Bloomberg~Kimmel Institute for Cancer Immunotherapy. If confirmed in additional studies, enoblituzumab could become the first promising antibody-based immunotherapy agent against prostate cancer.

Newly diagnosed people with Crohn’s disease in the United States are more likely to experience drug and alcohol use compared with the general population, according to a recent study led by Johns Hopkins Medicine researchers. The study, which used data from Medicaid between 2010–2019, found that 16.3% of enrollees had some form of substance use at the time of Crohn’s diagnosis, with alcohol and opioids being the most commonly used substances.

Johns Hopkins Medicine researchers collaborated with NASA to send human heart “tissue-on-a-chip” specimens into space in March aboard SpaceX CRS-27, a resupply mission to the International Space Station. The project is designed to monitor the tissue for changes in heart muscle cells’ mitochondria  and ability to contract in low-gravity conditions.

“Although we have a highly successful kidney transplant program, we’ve been limited — like other medical institutions — by the shortage of available human donor organs. Hopefully, xenotransplantation will soon be able to join other strong efforts at Johns Hopkins to address this challenge, such as our nondirected [altruistic] and directed [designated recipient] living donor programs.”

With a $35 million gift from researcher, philanthropist and race car driver Theodore Giovanis, scientists at Johns Hopkins Medicine will study the biological roots of the most fatal aspect of cancer: how it metastasizes, or spreads, through the body.

Jennifer Nickoles, who has served as interim president of Johns Hopkins Bayview Medical Center since July 2022, was named president in April.

"The AMA has been devoting a lot of attention to the opioid epidemic, and some attention to incarcerated populations, but the issue of pregnant incarcerated people with opioid use disorder has not really crossed its radar. It was very gratifying for them to take an interest and recognize the critical issues that this population faces.”

Johns Hopkins’ Jeremy Greene, a noted historian of how medical technology influences our understandings of sickness and health, has been awarded a Guggenheim Fellowship — one of 171 scientists, writers, scholars and artists selected for the prestigious honor from a pool of nearly 2,500 applicants.

The number of Johns Hopkins Ph.D. students across the university’s Ph.D. programs who will now be represented by TRU-UE (Teachers and Researchers United—United Electrical, Radio and Machine Workers of America) in collective bargaining with the university.

Five researchers from the Johns Hopkins University School of Medicine were elected as 2022 fellows of the American Association for the Advancement of Science — one of the highest distinctions in the global science community, which recognizes both achievements in science and scientific integrity. They join more than 500 researchers inducted into the 2022 class of fellows.

With Break the Cycle, violence intervention specialists help injured victims cope with deep trauma — ultimately interrupting the carnage that is claiming so many promising young lives in Baltimore.

Physicians face fraught decisions on a daily basis. A Johns Hopkins training program prepares trainees to navigate the human side of medicine.

How an innovative funding approach is advancing research and speeding treatments for patients whose complicated disorder can cause tumors on nerves all over the body. Every grant made by the Neurofibromatosis Therapeutic Acceleration Program, says neuro-oncologist Jaishri Blakeley, is bestowed with one question in mind: ‘How will this treatment get to clinic?’

Elaine Diggs, a former research assistant at Wilmer Eye Institute, wanted to develop a legacy gift that would reflect her passions. That’s why she decided to support vision rehabilitation at Wilmer.

Two clinician-scientists with a shared interest guide patients and families through the maze of living with genetic eye disease — and work to discover new cutting-edge therapies to treat it.

Volunteers become mentors for Asian American adoptees, learn about each other’s culture.

Experts in surgery and engineering test a wearable device that vibrates in response to the amount of force applied to tissue during surgical training.

At Johns Hopkins and across the country, children and adolescents are experiencing an unprecedented level of mental health challenges. Here are four ways experts at Johns Hopkins Children’s Center are confronting the crisis — with strategies aimed at getting young people the immediate support and treatment they need.

For these four young child life volunteers, fun is the name of the game

Johns Hopkins School of Medicine joins other top medical schools in withdrawing from U.S. News & World Report system

Evidence-based “Break the Cycle” program helps victims of gunshots and other violence work through trauma, avoid re-injury.

Johns Hopkins’ participation in the Chiari Surgical Success Scale and a similar study for nonsurgical patients could help doctors make better treatment decisions.

Social media has many pros and cons, but one of the things I have grown to love since becoming program director of the Osler Medical Residency is seeing pictures on Twitter of Osler residents and alumni out and about wearing their “Osler” scarf, tie, or socks on a Friday.

On March 17, 2023, the following 53 medical students matched into the Osler Medical Residency Program.

In this occasional series, we check in on alumni of Wilmer Eye Institute, Johns Hopkins Medicine’s ophthalmology residency program to see what they’ve been up to since graduating.

Bryce St. Clair, an optometrist at Wilmer Eye Institute, Johns Hopkins Medicine, has started a clinic in Baltimore that aims to help a population in the city that has been underserved.

In this occasional series, we check in on alumni of Wilmer Eye Institute, Johns Hopkins Medicine’s ophthalmology residency program to see what they’ve been up to since graduating.

Through larger samples of patient data from specialized clinics and multicenter studies, researchers and clinicians aim to better comprehend the origins of the condition.

Robin Yang leads the Johns Hopkins Division of Oral and Maxillofacial Surgery and Dentistry through growth and change.

Well-being of nursing staff, lowering HAPI risks and CAUTI rates, and early discharge are among the quality and safety initiatives.

Volunteers help support Meals on Wheels of Central Maryland, forge connections with the local community.

Johns Hopkins shoulder surgeon Uma Srikumaran expands scope of research and team members.

New research opens window into understanding the needs of patients after the procedure.

After a half-century of ophthalmology experience — with 25 of those years spent at Wilmer Eye Institute, Johns Hopkins Medicine — Mike Hartnett is set to retire in the coming weeks. Hartnett reflects on her career and the success of Wilmer’s technician training program, and discusses what’s next.

Mouen Khashab and colleagues combine peroral endoscopic myotomy and endoscopic fundoplication to improve patients’ lives. Johns Hopkins is only center in nation to provide the treatment.

In Jason Johnson’s first year with the Detroit Tigers, he said good-bye to between-innings blood tests.

A palliative care doctor finds rich rewards at the intersection of medicine and cartooning.

For this young child life volunteer, fun is the name of the game.

For this young child life volunteer, fun is the name of the game.

For this young child life volunteer, fun is the name of the game.

For this young child life volunteer, fun is the name of the game.

Hopkins Community Connection serves nearly 4,000 families a year.

Oncology infusion nurses bring special expertise and skill to the multi-disciplinary team providing monoclonal antibody infusions for people with COVID-19.

Our nurses have taken the lead to ensure the care at Sibley is of the highest quality, delivered according to best practices and based on the latest available evidence.

A left atrial appendage closure device gives doctors a minimally invasive treatment option for people with atrial fibrillation.

Marianne Cowley, M.D. joined Wilmer Eye Institute, Johns Hopkins Medicine as a clinical associate in March 2023. A retina specialist, Cowley sees patients at Wilmer’s Frederick clinic.

For more than 25 years, Mike Hartnett has been a confidant, an educator and a leader—some may even say a comedienne—at Wilmer Eye Institute, Johns Hopkins Medicine. Her work in the recruitment and development of ophthalmic technicians has proven invaluable to the organization. Many of the people whom she has impacted along the way are expressing gratitude.

With a multidisciplinary approach, endocrine surgeons and colleagues at Johns Hopkins offer spectrum of treatments.

The Johns Hopkins Human Aging Project is shedding light on the still-mysterious aging process.

Currently, there are 23 members of Wilmer Eye Institute, Johns Hopkins Medicine faculty who are alumni of Wilmer’s ophthalmic residency program. They span many different generations and decades, serve as experts and leaders in their respective fields and are instrumental in cultivating and mentoring the next generation of ophthalmologists. We asked them about their time as residents and how it has contributed to their careers.

Significant efforts are underway to support career advancement for women across the school of medicine.

More than 900 providers have completed the training with Johns Hopkins Medicine.

Director Stacy Suskauer leads a group with 11 pediatric physiatrists at four Johns Hopkins locations.

New service across Johns Hopkins Medicine connects medical interpreters with clinicians and patients in safe and efficient manner.

Physician-researchers in the Division of Laryngology advance clinical research and practice — leading studies on retrograde cricopharyngeal dysfunction, gender-affirming voice care and more.